Sony acquires Micronics, Inc., US diagnostic device development venture, Acquisition to accelerate development and commercialization of Point of Care diagnostic products
WEBWIRE – Wednesday, September 28, 2011
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
WEBWIRE – Wednesday, September 28, 2011
Veteran surgical devices maker and B. Braun Medical Inc. subsidiary Aesculap Inc. snapped up Aragon Surgical Inc. and its radiofrequency electrosurgical instruments for tissue fusion and cutting.
Aragon’s Caiman instruments are the only radiofrequency devices on the market with an articulating end to allow surgeons more maneuverability with tissue fusion and cutting during surgery.
Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery division agreed to acquire SterilMed Inc., a Minnesota medical device processor, for an undisclosed amount.
SterilMed reprocesses medical devices and also provides equipment repair and pre-owned equipment sales services. Johnson & Johnson said it plans to keep the SterilMed brand running as it integrates the business into the EES segment.
After a firm rejection of its buyout offer, Alere Inc. (NYSE:ALR) has started pleading to the sensibilities of Scottish competitor Axis-Sheild’s shareholders. This is not the first time the two firms have traded statements since Alere first offered its buyout in June.
Axis-Shield plc (“Axis-Shield” or the “Company”)
Response to Statement by Alere AS Holdings Limited (“Alere”), a wholly-owned subsidiary of Alere Inc.
The Board of Axis-Shield (the “Board”) notes today’s announcement released by Alere reiterating its unsolicited offer of 460 pence per share (the “Offer”).
The Board of Axis-Shield is disappointed that Alere has not taken notice of the firm rebuttal from shareholders to its wholly inadequate offer, made clear by the less than 1 per cent. level of acceptances it previously received as disclosed in Alere’s announcement of 16 September 2011.
Since Alere’s Rule 2.4 announcement on 6 July 2011, Axis-Shield has released a number of announcements, including its Interim Results for the six months ended 30 June 2011 (the “Interim Results”) and its shareholder circular (the “Defence Document”), none of which, in Alere’s opinion, have revealed any material new information.
Alere is disappointed that neither the Board of Axis-Shield, nor its advisors, have held any discussions or sought to engage with Alere, since the date that Alere announced its firm intention to make an offer for Axis-Shield.
HIMSS acquires so2say communications; expands media and communications services for the health-IT industry
The Healthcare Information and Management Systems Society (HIMSS) announces the acquisition of so2say communications, Ltd (so2say). so2say provides customized media products and communication services for the healthcare information technology industry. Its portfolio currently includes HealthTech Wire and the British Journal of Healthcare Computing.
HIMSS President and CEO H. Stephen Lieber, CAE, comments: “so2say has talented people, sought-after products and a strong vision to support the adoption of information technology in healthcare. The firm’s media and communications services help customers share information and engage with the audiences we both want to reach.”
Group Press Releases
Sage announces sale of US Healthcare division to Vista Equity Partners
22 September 2011
The Sage Group plc (”Sage”) today announces that it has reached a definitive agreement to sell Sage Software Healthcare LLC (”Sage Healthcare”), its subsidiary offering practice management and electronic health record solutions to US physician practices, to Vista Equity Partners. The cash proceeds for the sale are $320m (£205m*) and the sale is expected to complete in November 2011. Sage intends to return all of these proceeds to shareholders through a share buyback programme.
Sage Healthcare’s reported revenue for the half year ended 31 March 2011# was £72m with EBITA† of £10m.
Guy Berruyer, Sage Chief Executive, commented:
Integra LifeSciences Completes Acquisition of Ascension Orthopedics
PLAINSBORO, N.J., Sep 26, 2011 (GlobeNewswire via COMTEX) — Integra LifeSciences Holdings Corporation IART -1.26% today announced the closing of its previously announced acquisition of Ascension Orthopedics, Inc. (“Ascension.”) Ascension, based in Austin, Texas, develops and distributes a complementary range of implants for the shoulder, elbow, wrist, hand, foot and ankle.
“The acquisition of Ascension expands our platform in the fast-growing extremities space and provides us with access to the $600 million shoulder market,” said Stuart Essig, Integra’s Chief Executive Officer.